Innovative technology creates the future together｜Diagreat won the First Prize of Beijing Science and Technology Progress Award!

Great news for Diagreat

Warmly celebrate Diagreat

Winning the First Prize of Beijing Science and Technology Progress Award!

Diagreat won the First Prize of Beijing Science and Technology Progress Award, which is a recognition of its continuous efforts and innovative practices in the field of biomedicine over the years. Slowly but surely Diagreat has always been adhering to the concept of independent innovation and applying it to all aspects of the enterprise. From research and development, production to sales, it pays attention to technological innovation and quality control.

Science and Technology Progress Award

The 'Beijing Science and Technology Award' is an award established by the Beijing Municipal People's Government. The project awards include the Natural Science Award, the Technological Invention Award, and the Science and Technology Progress Award. In 2021, a total of 149 project achievements won the Beijing Science and Technology Progress Award, of which 37 achievements won the first prize of the Beijing Science and Technology Progress Award, and 112 achievements won the second prize of the Beijing Science and Technology Progress Award. This award is to implement the innovation-driven development strategy in depth, promote our city to accelerate the construction of a world's major science center and innovation highland, and focus on rewarding scientific and technological workers and achievements that have contributed to the construction of an international scientific and technological innovation center. Among them, the Science and Technology Progress Award focuses on the innovation and application of key technologies to support the development of key areas of the city. This award marks the affirmation and awards given by the country and society to IVD-related enterprises for their outstanding contributions in scientific and technological progress activities.

Diagreat takes serving the national strategic needs as its own responsibility, deeply cultivates technological innovation, and maintains the research and development speed of several new projects in the field of therapeutic drug monitoring every year, making more contributions to the realization of precision medicine for human health.

Diagreat won the First Prize for Scientific and Technological Progress Award in Beijing, which is not only an affirmation of its past efforts and achievements, but also a spur and encouragement for its future development. In the face of future challenges and opportunities, Diagreat will continue to adhere to the concept of independent innovation, unswervingly embark on a play for safty road, and contribute more to the development of the biomedical industry.

About Diagreat

Beijing Diagreat Biotechnologies Co., Ltd. (hereinafter referred to as 'Diagreat') was established in 2013, headquartered in Beijing Economic and Technological Development Zone, China.

Diagreat has mature research and production platforms for upstream key raw materials in the field of in vitro diagnostics and life science, including antibody research and development and production, protein engineering technology, enzyme molecular engineering technology, nucleic acid synthesis and modification, primer probes synthesis, gene sequencing, etc.

Diagreat has a series of in vitro diagnostic products domestic registration certificate, the core products include POCT series, Clinical Chemistry series, Chemiluminescence series, including Therapeutic Drug Monitoring (TDM) series of characteristic products. Series of products have also passed the CE certification, Italy, Mexico and Ecuador and other countries certification, and already sold to more than 60 countries and regions around the world.

Diagreat has dozens of patents for invention and successively won the First Prize for Scientific and Technological Progress Award in Beijing, Beijing Medical Science and Technology Award, the honorary titles of 'National High-tech Enterprise', 'Zhongguancun High-tech Enterprise', 'Beijing 'Specialization, Refinement, Differentiation, Innovation' of small and medium-sized Enterprises', 'Beijing Golden seed Enterprise', 'Yizhuang Deloitte Top 20 growth' and other honorary titles. Diagreat undertaken one national key scientific and technological research and development project and has successively completed a number of key scientific and technological research and development projects in Beijing, as well as a number of regional science and technology projects.